ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peroxisome Proliferator Activated Receptor Delta Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-1B10046
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Peroxisome Proliferator Activated Receptor Delta Market Insights Forecast to 2028
BUY CHAPTERS

Global Peroxisome Proliferator Activated Receptor Delta Market Research Report 2025

Code: QYRE-Auto-1B10046
Report
January 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chipscreen Biosciences Ltd
Connexios Life Sciences Pvt Ltd
CymaBay Therapeutics Inc
Genfit SA
Inventiva
Mitobridge
Nippon Chemiphar Co Ltd
Senju Pharmaceutical Co Ltd
T3D Therapeutics Inc

Peroxisome Proliferator Activated Receptor Delta Market

The global market for Peroxisome Proliferator Activated Receptor Delta was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Peroxisome Proliferator Activated Receptor Delta is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Peroxisome Proliferator Activated Receptor Delta is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Peroxisome Proliferator Activated Receptor Delta include Chipscreen Biosciences Ltd, Connexios Life Sciences Pvt Ltd, CymaBay Therapeutics Inc, Genfit SA, Inventiva, Mitobridge Inc, Nippon Chemiphar Co Ltd, Senju Pharmaceutical Co Ltd, T3D Therapeutics Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Peroxisome Proliferator Activated Receptor Delta, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peroxisome Proliferator Activated Receptor Delta.
The Peroxisome Proliferator Activated Receptor Delta market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peroxisome Proliferator Activated Receptor Delta market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peroxisome Proliferator Activated Receptor Delta manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Peroxisome Proliferator Activated Receptor Delta Market Report

Report Metric Details
Report Name Peroxisome Proliferator Activated Receptor Delta Market
Segment by Type
  • MTB-2
  • HPP-593
  • CNX-013B2
  • CS-038
  • MA-0204
  • Others
Segment by Application
  • Bone Disorders
  • Colitis
  • Obesity
  • Osteoporosis
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Chipscreen Biosciences Ltd, Connexios Life Sciences Pvt Ltd, CymaBay Therapeutics Inc, Genfit SA, Inventiva, Mitobridge Inc, Nippon Chemiphar Co Ltd, Senju Pharmaceutical Co Ltd, T3D Therapeutics Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Peroxisome Proliferator Activated Receptor Delta manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Peroxisome Proliferator Activated Receptor Delta in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Peroxisome Proliferator Activated Receptor Delta Market report?

Ans: The main players in the Peroxisome Proliferator Activated Receptor Delta Market are Chipscreen Biosciences Ltd, Connexios Life Sciences Pvt Ltd, CymaBay Therapeutics Inc, Genfit SA, Inventiva, Mitobridge Inc, Nippon Chemiphar Co Ltd, Senju Pharmaceutical Co Ltd, T3D Therapeutics Inc

What are the Application segmentation covered in the Peroxisome Proliferator Activated Receptor Delta Market report?

Ans: The Applications covered in the Peroxisome Proliferator Activated Receptor Delta Market report are Bone Disorders, Colitis, Obesity, Osteoporosis, Others

What are the Type segmentation covered in the Peroxisome Proliferator Activated Receptor Delta Market report?

Ans: The Types covered in the Peroxisome Proliferator Activated Receptor Delta Market report are MTB-2, HPP-593, CNX-013B2, CS-038, MA-0204, Others

1 Peroxisome Proliferator Activated Receptor Delta Market Overview
1.1 Product Definition
1.2 Peroxisome Proliferator Activated Receptor Delta by Type
1.2.1 Global Peroxisome Proliferator Activated Receptor Delta Market Value Comparison by Type (2024 VS 2031)
1.2.2 MTB-2
1.2.3 HPP-593
1.2.4 CNX-013B2
1.2.5 CS-038
1.2.6 MA-0204
1.2.7 Others
1.3 Peroxisome Proliferator Activated Receptor Delta by Application
1.3.1 Global Peroxisome Proliferator Activated Receptor Delta Market Value by Application (2024 VS 2031)
1.3.2 Bone Disorders
1.3.3 Colitis
1.3.4 Obesity
1.3.5 Osteoporosis
1.3.6 Others
1.4 Global Peroxisome Proliferator Activated Receptor Delta Market Size Estimates and Forecasts
1.4.1 Global Peroxisome Proliferator Activated Receptor Delta Revenue 2020-2031
1.4.2 Global Peroxisome Proliferator Activated Receptor Delta Sales 2020-2031
1.4.3 Global Peroxisome Proliferator Activated Receptor Delta Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Peroxisome Proliferator Activated Receptor Delta Market Competition by Manufacturers
2.1 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Manufacturers (2020-2025)
2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Peroxisome Proliferator Activated Receptor Delta Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Peroxisome Proliferator Activated Receptor Delta, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Product Type & Application
2.7 Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Date of Enter into This Industry
2.8 Global Peroxisome Proliferator Activated Receptor Delta Market Competitive Situation and Trends
2.8.1 Global Peroxisome Proliferator Activated Receptor Delta Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Peroxisome Proliferator Activated Receptor Delta Players Market Share by Revenue
2.8.3 Global Peroxisome Proliferator Activated Receptor Delta Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Peroxisome Proliferator Activated Receptor Delta Market Scenario by Region
3.1 Global Peroxisome Proliferator Activated Receptor Delta Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Peroxisome Proliferator Activated Receptor Delta Sales by Region: 2020-2031
3.2.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Region: 2020-2025
3.2.2 Global Peroxisome Proliferator Activated Receptor Delta Sales by Region: 2026-2031
3.3 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region: 2020-2031
3.3.1 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region: 2020-2025
3.3.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region: 2026-2031
3.4 North America Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures by Country
3.4.1 North America Peroxisome Proliferator Activated Receptor Delta Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2020-2031)
3.4.3 North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures by Country
3.5.1 Europe Peroxisome Proliferator Activated Receptor Delta Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2020-2031)
3.5.3 Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures by Region
3.6.1 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2020-2031)
3.6.3 Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures by Country
3.7.1 Latin America Peroxisome Proliferator Activated Receptor Delta Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2020-2031)
3.7.3 Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Market Facts & Figures by Country
3.8.1 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2020-2031)
3.8.3 Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2020-2031)
4.1.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2020-2025)
4.1.2 Global Peroxisome Proliferator Activated Receptor Delta Sales by Type (2026-2031)
4.1.3 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2020-2031)
4.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2020-2031)
4.2.1 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2020-2025)
4.2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Type (2026-2031)
4.2.3 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2020-2031)
4.3 Global Peroxisome Proliferator Activated Receptor Delta Price by Type (2020-2031)
5 Segment by Application
5.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2020-2031)
5.1.1 Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2020-2025)
5.1.2 Global Peroxisome Proliferator Activated Receptor Delta Sales by Application (2026-2031)
5.1.3 Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2020-2031)
5.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2020-2031)
5.2.1 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2020-2025)
5.2.2 Global Peroxisome Proliferator Activated Receptor Delta Revenue by Application (2026-2031)
5.2.3 Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2020-2031)
5.3 Global Peroxisome Proliferator Activated Receptor Delta Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Chipscreen Biosciences Ltd
6.1.1 Chipscreen Biosciences Ltd Company Information
6.1.2 Chipscreen Biosciences Ltd Description and Business Overview
6.1.3 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.1.5 Chipscreen Biosciences Ltd Recent Developments/Updates
6.2 Connexios Life Sciences Pvt Ltd
6.2.1 Connexios Life Sciences Pvt Ltd Company Information
6.2.2 Connexios Life Sciences Pvt Ltd Description and Business Overview
6.2.3 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.2.5 Connexios Life Sciences Pvt Ltd Recent Developments/Updates
6.3 CymaBay Therapeutics Inc
6.3.1 CymaBay Therapeutics Inc Company Information
6.3.2 CymaBay Therapeutics Inc Description and Business Overview
6.3.3 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2020-2025)
6.3.4 CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.3.5 CymaBay Therapeutics Inc Recent Developments/Updates
6.4 Genfit SA
6.4.1 Genfit SA Company Information
6.4.2 Genfit SA Description and Business Overview
6.4.3 Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Genfit SA Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.4.5 Genfit SA Recent Developments/Updates
6.5 Inventiva
6.5.1 Inventiva Company Information
6.5.2 Inventiva Description and Business Overview
6.5.3 Inventiva Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Inventiva Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.5.5 Inventiva Recent Developments/Updates
6.6 Mitobridge Inc
6.6.1 Mitobridge Inc Company Information
6.6.2 Mitobridge Inc Description and Business Overview
6.6.3 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.6.5 Mitobridge Inc Recent Developments/Updates
6.7 Nippon Chemiphar Co Ltd
6.7.1 Nippon Chemiphar Co Ltd Company Information
6.7.2 Nippon Chemiphar Co Ltd Description and Business Overview
6.7.3 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.7.5 Nippon Chemiphar Co Ltd Recent Developments/Updates
6.8 Senju Pharmaceutical Co Ltd
6.8.1 Senju Pharmaceutical Co Ltd Company Information
6.8.2 Senju Pharmaceutical Co Ltd Description and Business Overview
6.8.3 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.8.5 Senju Pharmaceutical Co Ltd Recent Developments/Updates
6.9 T3D Therapeutics Inc
6.9.1 T3D Therapeutics Inc Company Information
6.9.2 T3D Therapeutics Inc Description and Business Overview
6.9.3 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales, Revenue and Gross Margin (2020-2025)
6.9.4 T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product Portfolio
6.9.5 T3D Therapeutics Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peroxisome Proliferator Activated Receptor Delta Industry Chain Analysis
7.2 Peroxisome Proliferator Activated Receptor Delta Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peroxisome Proliferator Activated Receptor Delta Production Mode & Process Analysis
7.4 Peroxisome Proliferator Activated Receptor Delta Sales and Marketing
7.4.1 Peroxisome Proliferator Activated Receptor Delta Sales Channels
7.4.2 Peroxisome Proliferator Activated Receptor Delta Distributors
7.5 Peroxisome Proliferator Activated Receptor Delta Customer Analysis
8 Peroxisome Proliferator Activated Receptor Delta Market Dynamics
8.1 Peroxisome Proliferator Activated Receptor Delta Industry Trends
8.2 Peroxisome Proliferator Activated Receptor Delta Market Drivers
8.3 Peroxisome Proliferator Activated Receptor Delta Market Challenges
8.4 Peroxisome Proliferator Activated Receptor Delta Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Chipscreen Biosciences Ltd
Connexios Life Sciences Pvt Ltd
CymaBay Therapeutics Inc
Genfit SA
Inventiva
Mitobridge
Nippon Chemiphar Co Ltd
Senju Pharmaceutical Co Ltd
T3D Therapeutics Inc
List of Tables
 Table 1. Global Peroxisome Proliferator Activated Receptor Delta Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Peroxisome Proliferator Activated Receptor Delta Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Peroxisome Proliferator Activated Receptor Delta Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) of Key Manufacturers (2020-2025)
 Table 5. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Peroxisome Proliferator Activated Receptor Delta Average Price (USD/Pcs) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Peroxisome Proliferator Activated Receptor Delta, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Product Type & Application
 Table 12. Global Key Manufacturers of Peroxisome Proliferator Activated Receptor Delta, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Peroxisome Proliferator Activated Receptor Delta by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peroxisome Proliferator Activated Receptor Delta as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Peroxisome Proliferator Activated Receptor Delta Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2020-2025) & (K Pcs)
 Table 18. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2020-2025)
 Table 19. Global Peroxisome Proliferator Activated Receptor Delta Sales by Region (2026-2031) & (K Pcs)
 Table 20. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2026-2031)
 Table 21. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region (2020-2025)
 Table 23. Global Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region (2026-2031)
 Table 25. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2020-2025) & (K Pcs)
 Table 27. North America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2026-2031) & (K Pcs)
 Table 28. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2020-2025) & (K Pcs)
 Table 32. Europe Peroxisome Proliferator Activated Receptor Delta Sales by Country (2026-2031) & (K Pcs)
 Table 33. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2020-2025) & (K Pcs)
 Table 37. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales by Region (2026-2031) & (K Pcs)
 Table 38. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2020-2025) & (K Pcs)
 Table 42. Latin America Peroxisome Proliferator Activated Receptor Delta Sales by Country (2026-2031) & (K Pcs)
 Table 43. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2020-2025) & (K Pcs)
 Table 47. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales by Country (2026-2031) & (K Pcs)
 Table 48. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2020-2025)
 Table 51. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Type (2026-2031)
 Table 52. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2020-2025)
 Table 53. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Type (2026-2031)
 Table 54. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2020-2025)
 Table 57. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Type (2026-2031)
 Table 58. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Type (2020-2025)
 Table 59. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Type (2026-2031)
 Table 60. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2020-2025)
 Table 61. Global Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs) by Application (2026-2031)
 Table 62. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2020-2025)
 Table 63. Global Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Application (2026-2031)
 Table 64. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Peroxisome Proliferator Activated Receptor Delta Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2020-2025)
 Table 67. Global Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Application (2026-2031)
 Table 68. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Application (2020-2025)
 Table 69. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Application (2026-2031)
 Table 70. Chipscreen Biosciences Ltd Company Information
 Table 71. Chipscreen Biosciences Ltd Description and Business Overview
 Table 72. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 73. Chipscreen Biosciences Ltd Peroxisome Proliferator Activated Receptor Delta Product
 Table 74. Chipscreen Biosciences Ltd Recent Developments/Updates
 Table 75. Connexios Life Sciences Pvt Ltd Company Information
 Table 76. Connexios Life Sciences Pvt Ltd Description and Business Overview
 Table 77. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 78. Connexios Life Sciences Pvt Ltd Peroxisome Proliferator Activated Receptor Delta Product
 Table 79. Connexios Life Sciences Pvt Ltd Recent Developments/Updates
 Table 80. CymaBay Therapeutics Inc Company Information
 Table 81. CymaBay Therapeutics Inc Description and Business Overview
 Table 82. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 83. CymaBay Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product
 Table 84. CymaBay Therapeutics Inc Recent Developments/Updates
 Table 85. Genfit SA Company Information
 Table 86. Genfit SA Description and Business Overview
 Table 87. Genfit SA Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 88. Genfit SA Peroxisome Proliferator Activated Receptor Delta Product
 Table 89. Genfit SA Recent Developments/Updates
 Table 90. Inventiva Company Information
 Table 91. Inventiva Description and Business Overview
 Table 92. Inventiva Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 93. Inventiva Peroxisome Proliferator Activated Receptor Delta Product
 Table 94. Inventiva Recent Developments/Updates
 Table 95. Mitobridge Inc Company Information
 Table 96. Mitobridge Inc Description and Business Overview
 Table 97. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 98. Mitobridge Inc Peroxisome Proliferator Activated Receptor Delta Product
 Table 99. Mitobridge Inc Recent Developments/Updates
 Table 100. Nippon Chemiphar Co Ltd Company Information
 Table 101. Nippon Chemiphar Co Ltd Description and Business Overview
 Table 102. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 103. Nippon Chemiphar Co Ltd Peroxisome Proliferator Activated Receptor Delta Product
 Table 104. Nippon Chemiphar Co Ltd Recent Developments/Updates
 Table 105. Senju Pharmaceutical Co Ltd Company Information
 Table 106. Senju Pharmaceutical Co Ltd Description and Business Overview
 Table 107. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 108. Senju Pharmaceutical Co Ltd Peroxisome Proliferator Activated Receptor Delta Product
 Table 109. Senju Pharmaceutical Co Ltd Recent Developments/Updates
 Table 110. T3D Therapeutics Inc Company Information
 Table 111. T3D Therapeutics Inc Description and Business Overview
 Table 112. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
 Table 113. T3D Therapeutics Inc Peroxisome Proliferator Activated Receptor Delta Product
 Table 114. T3D Therapeutics Inc Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Peroxisome Proliferator Activated Receptor Delta Distributors List
 Table 118. Peroxisome Proliferator Activated Receptor Delta Customers List
 Table 119. Peroxisome Proliferator Activated Receptor Delta Market Trends
 Table 120. Peroxisome Proliferator Activated Receptor Delta Market Drivers
 Table 121. Peroxisome Proliferator Activated Receptor Delta Market Challenges
 Table 122. Peroxisome Proliferator Activated Receptor Delta Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Peroxisome Proliferator Activated Receptor Delta
 Figure 2. Global Peroxisome Proliferator Activated Receptor Delta Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peroxisome Proliferator Activated Receptor Delta Market Share by Type: 2024 & 2031
 Figure 4. MTB-2 Product Picture
 Figure 5. HPP-593 Product Picture
 Figure 6. CNX-013B2 Product Picture
 Figure 7. CS-038 Product Picture
 Figure 8. MA-0204 Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global Peroxisome Proliferator Activated Receptor Delta Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global Peroxisome Proliferator Activated Receptor Delta Market Share by Application: 2024 & 2031
 Figure 12. Bone Disorders
 Figure 13. Colitis
 Figure 14. Obesity
 Figure 15. Osteoporosis
 Figure 16. Others
 Figure 17. Global Peroxisome Proliferator Activated Receptor Delta Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global Peroxisome Proliferator Activated Receptor Delta Market Size (2020-2031) & (US$ Million)
 Figure 19. Global Peroxisome Proliferator Activated Receptor Delta Sales (2020-2031) & (K Pcs)
 Figure 20. Global Peroxisome Proliferator Activated Receptor Delta Average Price (USD/Pcs) & (2020-2031)
 Figure 21. Peroxisome Proliferator Activated Receptor Delta Report Years Considered
 Figure 22. Peroxisome Proliferator Activated Receptor Delta Sales Share by Manufacturers in 2024
 Figure 23. Global Peroxisome Proliferator Activated Receptor Delta Revenue Share by Manufacturers in 2024
 Figure 24. Global 5 and 10 Largest Peroxisome Proliferator Activated Receptor Delta Players: Market Share by Revenue in Peroxisome Proliferator Activated Receptor Delta in 2024
 Figure 25. Peroxisome Proliferator Activated Receptor Delta Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Global Peroxisome Proliferator Activated Receptor Delta Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 27. North America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Country (2020-2031)
 Figure 28. North America Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Country (2020-2031)
 Figure 29. U.S. Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Canada Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Europe Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Country (2020-2031)
 Figure 32. Europe Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Country (2020-2031)
 Figure 33. Germany Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. France Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. U.K. Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Italy Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Russia Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Region (2020-2031)
 Figure 39. Asia Pacific Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Region (2020-2031)
 Figure 40. China Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Japan Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. South Korea Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. India Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Australia Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Taiwan Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Indonesia Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Thailand Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Malaysia Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Philippines Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Sales Market Share by Country (2020-2031)
 Figure 56. Middle East and Africa Peroxisome Proliferator Activated Receptor Delta Revenue Market Share by Country (2020-2031)
 Figure 57. Turkey Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Saudi Arabia Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. U.A.E Peroxisome Proliferator Activated Receptor Delta Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. Global Sales Market Share of Peroxisome Proliferator Activated Receptor Delta by Type (2020-2031)
 Figure 61. Global Revenue Market Share of Peroxisome Proliferator Activated Receptor Delta by Type (2020-2031)
 Figure 62. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Type (2020-2031)
 Figure 63. Global Sales Market Share of Peroxisome Proliferator Activated Receptor Delta by Application (2020-2031)
 Figure 64. Global Revenue Market Share of Peroxisome Proliferator Activated Receptor Delta by Application (2020-2031)
 Figure 65. Global Peroxisome Proliferator Activated Receptor Delta Price (USD/Pcs) by Application (2020-2031)
 Figure 66. Peroxisome Proliferator Activated Receptor Delta Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global PPARδ Agonist Market Research Report 2025
Global PPARα Agonist Market Research Report 2025
Global Prostaglandin D2 Receptor 2 Market Research Report 2025
Global Delta Decalactones Market Research Report 2025
Global Pioglitazone Hydrochloride Market Research Report 2025
Global Retinoic Acid Receptor Alpha Market Research Report 2024
Global Delta Tocopherol Market Research Report 2024
Global delta Octanolactone Market Research Report 2024
Global Delta Octalactone Market Research Report 2025
Global Delta octadecalactone Market Research Report 2024
Global Retinoic Acid Receptor Beta Market Research Report 2024
Global Phosphatidic Acid Market Research Report 2025
Global Pioglitazone HCL Market Research Report 2024
Global Retinoic Acid Receptor Gamma Market Research Report 2024
Global Leptin Receptor Market Research Report 2024
Global Food Grade Delta Decalactone Market Research Report 2025
Global Diisopropanolamine DIPA Market Research Report 2025
Global Interleukin 2 Receptor Subunit Alpha Market Research Report 2025
Global 1 2 Propanediol Diacetate Market Research Report 2025
Global Delta Nonalactone Market Research Report 2025

RELATED REPORTS

Global Nano Porous Silicon–carbon Anode Material Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0F17509
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Foam Board Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16F19834
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Copper Wires Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5U6954
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Quartz Fiber Cloth Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20G17359
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions